|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002199,
umls-concept:C0027627,
umls-concept:C0031928,
umls-concept:C0205179,
umls-concept:C0205314,
umls-concept:C0442027,
umls-concept:C0679622,
umls-concept:C0879262,
umls-concept:C1511962,
umls-concept:C1517058,
umls-concept:C1521750,
umls-concept:C2239176
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2008-4-10
|
|
pubmed:abstractText |
To the authors' knowledge, there is no effective therapy for extrahepatic metastasis of hepatocellular carcinoma (HCC). In a pilot study, the results of combination therapy of S-1, a novel oral dehydropyrimidine dehydrogenase (DPD) inhibitor, and interferon-alpha (IFN-alpha) are reported for HCC patients with extrahepatic metastasis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:DonoKeizoK,
pubmed-author:KobayashiShogoS,
pubmed-author:MarubashiShigeruS,
pubmed-author:MiyamotoAtsushiA,
pubmed-author:MondenMoritoM,
pubmed-author:NaganoHiroakiH,
pubmed-author:NakamuraMasatoM,
pubmed-author:NodaTakehiroT,
pubmed-author:TakedaYutakaY,
pubmed-author:UmeshitaKojiK,
pubmed-author:WadaHiroshiH
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
112
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1765-71
|
|
pubmed:meshHeading |
pubmed-meshheading:18327806-Administration, Oral,
pubmed-meshheading:18327806-Adult,
pubmed-meshheading:18327806-Aged,
pubmed-meshheading:18327806-Antimetabolites, Antineoplastic,
pubmed-meshheading:18327806-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18327806-Carcinoma, Hepatocellular,
pubmed-meshheading:18327806-Dihydrouracil Dehydrogenase (NADP),
pubmed-meshheading:18327806-Drug Combinations,
pubmed-meshheading:18327806-Female,
pubmed-meshheading:18327806-Follow-Up Studies,
pubmed-meshheading:18327806-Humans,
pubmed-meshheading:18327806-Immunologic Factors,
pubmed-meshheading:18327806-Injections, Subcutaneous,
pubmed-meshheading:18327806-Interferon-alpha,
pubmed-meshheading:18327806-Leukopenia,
pubmed-meshheading:18327806-Liver Neoplasms,
pubmed-meshheading:18327806-Male,
pubmed-meshheading:18327806-Middle Aged,
pubmed-meshheading:18327806-Oxonic Acid,
pubmed-meshheading:18327806-Pilot Projects,
pubmed-meshheading:18327806-Remission Induction,
pubmed-meshheading:18327806-Survival Rate,
pubmed-meshheading:18327806-Tegafur,
pubmed-meshheading:18327806-Thrombocytopenia
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis.
|
|
pubmed:affiliation |
Department of Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
